You are here

psoriasis

Novartis snags new approvals for Cosentyx in Europe

Fierce Pharma

Tue, 11/24/15 - 09:49 am

Pfizer gives up on a pair of Xeljanz indications--and it may dump psoriasis, too

Fierce Pharma

Thu, 10/29/15 - 09:05 am

ankylosing spondylitis

Chron's Disease

Boehringer's psoriasis drug beats Stelara in head-to-head Phase II

Fierce Biotech

Fri, 10/9/15 - 10:36 am

Boehringer Ingelheim

Drug maker scratches employees, shakes up C-suite after psoriasis drug troubles

Bizjournals.com

Mon, 10/5/15 - 06:03 pm

Novartis stacks up more data for lucrative Cosentyx expansion

Fierce Pharma

Thu, 10/1/15 - 02:08 pm

What in the World Happened to XenoPort?

Barron's

Tue, 09/15/15 - 03:15 pm

XenoPort's psoriasis drug found effective; shares jump

Yahoo/Reuters

Tue, 09/15/15 - 08:54 am

AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal

Fierce Biotech

Tue, 09/1/15 - 09:55 am

Valeant Pharmaceuticals

AstraZeneca isn't giving up on brodalumab despite its links to suicide

Fierce Biotech

Fri, 07/31/15 - 03:16 pm

J&J's Stelara may be under fire in psoriasis, but it's positioned to score elsewhere

Fierce Pharma Marketing

Fri, 07/24/15 - 05:59 pm

J&J chief touts $1B-plus prospects for coming psoriasis med guselkumab

Fierce Pharma Marketing

Wed, 07/15/15 - 11:27 am

Johnson & Johnson: Experimental drug clears more psoriasis patches than rival AbbVie's Humira

Yahoo/AP

Thu, 07/9/15 - 10:13 am

New data fuel hopes for broad use of Novartis psoriasis drug

Yahoo/Reuters

Mon, 06/29/15 - 10:46 am

Sales Of This Eli Lilly Drug Could Nearly Double Wall St. Consensus In 2020, SunTrust Predicts

Yahoo/Benzinga

Wed, 06/24/15 - 01:10 pm

AstraZeneca Near Decision on Suicide-Linked Drug, CEO Says

Bloomberg

Tue, 06/2/15 - 09:09 am

Can AZ salvage brodalumab against next-gen psoriasis field?

Fierce Pharma Marketing

Tue, 05/26/15 - 08:07 pm

Psoriasis data wars heat up at AAD with Novartis, Boehringer studies

Fierce Pharma Marketing

Thu, 03/26/15 - 07:38 am

Boehringer Ingelheim

Here comes the blockbuster: Novartis' Cosentyx bests Stelara in psoriasis trials

BioPharma Dive

Mon, 03/23/15 - 10:36 am

Pfizer Announces Oral Tofacitinib Meets Primary Endpoints In Pivotal Phase 3 Psoriasis Trials

Yahoo

Fri, 03/20/15 - 08:28 pm

Novartis AG (ADR) Cosentyx More Effective Than Johnson & Johnson Stelara

Bidness Etc.

Sat, 03/14/15 - 03:04 pm

Pages